NASDAQ:PRPH ProPhase Labs (PRPH) Stock Price, News & Analysis $0.01 0.00 (-2.91%) As of 12:47 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsNews and TrendsOwnershipSEC Filings About ProPhase Labs Stock (NASDAQ:PRPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get ProPhase Labs alerts:Sign Up Key Stats Today's Range$0.0095▼$0.011150-Day Range$0.01▼$0.0552-Week Range$0.01▼$5.62Volume1.06 million shsAverage Volume231,688 shsMarket Capitalization$190.23 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview ProPhase Labs, Inc. is a diversified health and wellness company focused on diagnostics, genomics, consumer healthcare products and related biopharmaceutical opportunities. The company operates through businesses that develop and commercialize products and services intended to support disease detection, personalized health information and consumer wellness. Its consumer healthcare operations include Cold-EEZE zinc-based products, which are marketed in forms such as lozenges and oral sprays for common-cold symptom support. ProPhase Labs has also been involved in laboratory testing and diagnostic services through its ProPhase Diagnostics business, including molecular testing capabilities developed during the COVID-19 pandemic. The company expanded into genomics through its acquisition of Nebula Genomics, a business focused on whole-genome sequencing and enabling individuals to access and control their genetic data. ProPhase Labs serves customers primarily in the United States, with certain consumer products distributed through retail and other commercial channels. Ted Karkus serves as the company’s chairman and chief executive officer. The company was formerly known as The Quigley Corporation before adopting the ProPhase Labs name.AI Generated. May Contain Errors. Read More Receive PRPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProPhase Labs and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRPH Stock News HeadlinesProPhase Labs (NASDAQ:PRPH) Stock Breaks Below 200 Day Moving Average - Here's What HappenedOctober 8 at 3:21 AM | americanbankingnews.comAurora Cannabis (NASDAQ:ACB) & ProPhase Labs (NASDAQ:PRPH) Financial ComparisonOctober 7 at 5:28 AM | americanbankingnews.comThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.October 8 at 1:00 AM | Golden Portfolio (Ad)ProPhase Labs (NASDAQ:PRPH) Share Price Breaks Below 200 Day Moving Average - Here's What HappenedSeptember 30, 2026 | americanbankingnews.comProPhase Labs Delays Quarterly SEC FilingAugust 14, 2026 | tipranks.comProPhase Labs Inc.July 16, 2026 | marketwatch.comProPhase Labs Announces Immediate Resignation of Board MemberJune 25, 2026 | theglobeandmail.comProPhase Labs Delays Quarterly Financial FilingMay 15, 2026 | tipranks.comSee More Headlines PRPH Stock Analysis - Frequently Asked Questions How have PRPH shares performed this year? ProPhase Labs' stock was trading at $0.4475 at the start of the year. Since then, PRPH stock has decreased by 97.8% and is now trading at $0.01. How were ProPhase Labs' earnings last quarter? ProPhase Labs, Inc. (NASDAQ:PRPH) released its quarterly earnings results on Wednesday, November, 19th. The company reported ($1.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.10) by $0.50. The business earned $0.88 million during the quarter, compared to the consensus estimate of $5.69 million. ProPhase Labs had a negative trailing twelve-month return on equity of 482.05% and a negative net margin of 825.01%. Read the conference call transcript. When did ProPhase Labs' stock split? Shares of ProPhase Labs reverse split on Monday, December 22nd 2025.A 1-10 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, December 21st 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of ProPhase Labs? Shares of PRPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ProPhase Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that ProPhase Labs investors own include Meta Platforms (META), Pfizer (PFE), Valero Energy (VLO), Catalyst Pharmaceuticals (CPRX) and Energy Transfer (ET). Company Calendar Last Earnings11/19/2025Today10/08/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (10m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 PRPH's financial health is in the Red zone, according to TradeSmith. PRPH has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:PRPH CIK868278 Webwww.prophaselabs.com Phone(215) 345-0919Fax215-345-5920Employees130Year Founded1981Profitability EPS (Trailing Twelve Months)($2.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$53.36 million Net Margins-825.01% Pretax Margin-680.20% Return on Equity-482.05% Return on Assets-88.90% Debt Debt-to-Equity Ratio0.14 Current Ratio0.14 Quick Ratio0.14 Sales & Book Value Annual Sales$5.06 million Price / Sales0.04 Cash FlowN/A Price / Cash FlowN/A Book Value$2.46 per share Price / Book0.00Miscellaneous Outstanding Shares19,023,000Free Float5,444,000Market Cap$190.23 thousand OptionableNo Data Beta0.13 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:PRPH) was last updated on 10/8/2026 by MarketBeat.com Staff. From Our PartnersA dividend every week of the yearMost dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...Market Savvy | SponsoredThe national debt just passed $39 trillionThe U.S. national debt just topped $39 trillion, up nearly $3 trillion in a single year and on pace to hit $40...US Gold Bureau | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | Sponsored"The largest market in human history"SpaceX quietly filed paperwork describing what it calls the largest actionable total addressable market in hum...Behind the Markets | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProPhase Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProPhase Labs With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRPH Stock Alerts